Redmile Group, LLC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 86 filers reported holding RAPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,104,884
-12.0%
427,490
-1.0%
0.34%
+9.0%
Q2 2023$8,076,885
-36.0%
431,919
-37.2%
0.31%
-43.4%
Q1 2023$12,627,222
-18.7%
688,132
-12.3%
0.55%
-13.8%
Q4 2022$15,539,674
-17.7%
784,8320.0%0.64%
-13.1%
Q3 2022$18,883,000
+26.5%
784,832
-4.0%
0.73%
+28.4%
Q2 2022$14,925,000
-9.3%
817,832
+9.2%
0.57%
+10.9%
Q1 2022$16,463,000748,6770.51%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$44,551,92129.58%
GREAT POINT PARTNERS LLC 1,458,070$24,233,1234.41%
Euclidean Capital LLC 1,315,798$21,868,5622.39%
Trustees of Columbia University in the City of New York 73,383$1,219,6252.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 805,828$13,392,8611.54%
Perceptive Advisors 1,920,658$31,921,3361.06%
Deep Track Capital, LP 1,500,000$24,930,0000.96%
Cheyne Capital Management (UK) LLP 20,000$332,4000.96%
Alphabet Inc. 540,270$8,979,2870.58%
BRAIDWELL LP 1,082,512$17,991,3490.57%
View complete list of RAPT THERAPEUTICS INC shareholders